TableĀ 3 Association between the three CD38 cutoff levels and the study variables
From: Evaluation of CD38 expression in Sudanese patients with chronic lymphocytic leukemia
Variables | 7% cutoff level | 20% cutoff level | 30% cutoff level | ||||||
|---|---|---|---|---|---|---|---|---|---|
CD38+ | CD38ā | P value | CD38+ | CD38ā | P value | CD38+ | CD38ā | P-value | |
Age (%) | |||||||||
ā„ā60 | 46.5 | 19.2 | 0.64 | 28.3 | 37.4 | 0.41 | 25.3 | 40.4 | 0.53 |
<ā60 | 22.2 | 12.1 | 13.1 | 21.2 | 11.1 | 23.2 | |||
Sex (%) | |||||||||
Male | 51.5 | 18.2 | 0.09 | 31.3 | 38.4 | 0.28 | 27.3 | 42.4 | 0.39 |
Female | 17.2 | 13.1 | 10.1 | 20.2 | 9.1 | 21.2 | |||
Lymphadenopathy (%) | |||||||||
Not found | 20.2 | 8.1 | 0.49 | 11.1 | 17.2 | 0.68 | 10.1 | 18.2 | 0.37 |
One site | 2.0 | 2.0 | 1.0 | 3.0 | 0.0 | 4.0 | |||
Two sites | 9.1 | 1.0 | 5.1 | 5.1 | 5.1 | 5.1 | |||
Three sites | 1.0 | 1.0 | 0.0 | 2.0 | 0.0 | 2.0 | |||
More than three sites | 36.4 | 19.2 | 24.2 | 31.3 | 21.2 | 34.3 | |||
Splenomegaly (%) | |||||||||
Present | 35.4 | 17.2 | 0.76 | 22.2 | 30.3 | 0.86 | 20.2 | 32.3 | 0.65 |
Absent | 33.3 | 14.1 | 19.2 | 28.3 | 16.2 | 31.3 | |||
Hepatomegaly (%) | |||||||||
Present | 18.2 | 7.1 | 0.68 | 13.1 | 12.1 | 0.21 | 11.1 | 14.1 | 0.36 |
Absent | 50.5 | 24.2 | 28.3 | 46.5 | 25.3 | 49.5 | |||
Hemoglobin concentration (g/dl) (%) | |||||||||
Severe | 11.1 | 1.0 | 0.04* | 6.1 | 6.1 | 0.67 | 6.1 | 6.1 | 0.57 |
Moderate | 18.2 | 14.1 | 11.1 | 21.2 | 11.1 | 21.2 | |||
Mild | 17.2 | 11.1 | 11.1 | 17.2 | 8.0 | 20.2 | |||
No anemia | 22.2 | 5.1 | 13.1 | 14.1 | 11.1 | 16.2 | |||
TWBCs countāĆā10 9 (%) | |||||||||
<ā50 | 26.3 | 8.1) | 0.10 | 13.1 | 21.2 | 0.59 | 12.1 | 22.2 | 0.83 |
ā„ā50 | 42.4 | 23.2 | 28.3 | 37.4 | 24.2 | 41.4 | |||
Platelet countāĆā10 9 (%) | |||||||||
<ā150 | 26.3 | 13.1 | 0.94 | 16.1 | 23.2 | 0.97 | 14.1 | 25.3 | 0.71 |
ā„ā150 | 42.4 | 18.2 | 25.3 | 35.4 | 22.2 | 38.4 | |||
Modified Rai staging system (%) | |||||||||
High risk group | 44.4 | 20.2 | 0.54 | 26.3 | 37.4 | 0.10 | 18.2 | 46.5 | 0.99 |
Intermediate risk group | 22.2 | 8.0 | 13.1 | 18.2 | 17.2 | 13.1 | |||
Low risk group | 2.0 | 3.0 | 2.0 | 3.0 | 1.0 | 4.0 | |||